AI Market Mood: Stock Dashboard
IMNM
Fundamental
Company: Immunome Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -2.96
Insider Own: 8.27%
Shs Outstand: 110.33M
Perf Week: -10.93%
Market Cap: 2.45B
Forward P/E: -
EPS next Y: -2.52
Insider Trans: -3.33%
Shs Float: 101.22M
Perf Month: 6.74%
Enterprise Value: 2.18B
PEG: -
EPS next Q: -0.59
Inst Own: 89.14%
Short Float: 15.58%
Perf Quarter: 27.14%
Income: -222.74M
P/S: 252.59
EPS this Y: 55.12%
Inst Trans: 10.95%
Short Ratio: 7.47
Perf Half Y: 122.94%
Sales: 9.68M
P/B: 7.70
EPS next Y Percentage: -12.49%
ROA: -80.08%
Short Interest: 15.77M
Perf YTD: 3.17%
Book/sh: 2.88
P/C: 8.97
EPS next 5Y: 24.09%
ROE: -93.04%
52W High: 27.65 -19.86%
Perf Year: 112.46%
Cash/sh: 2.47
P/FCF: -
EPS past 3/5Y: -32.63% -38.15%
ROIC: -83.13%
52W Low: 5.15 330.28%
Perf 3Y: 309.61%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: 71.34%
Volatility W: 6.44%
Volatility M: 6.99%
Perf 5Y: -10.17%
Dividend TTM: -
EV/Sales: 224.83
EPS Y/Y TTM: 63.58%
Oper. Margin: -2137.10%
ATR (14): 1.59
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 8.90
Sales Y/Y TTM: -4.44%
Profit Margin: -2301.30%
RSI (14): 43.23
Recom: 1.00
Dividend Gr. 3/5Y: - -
Current Ratio: 8.90
EPS Q/Q: 16.50%
SMA20: -10.33%
Beta: 2.12
Target Price: 35.08
Payout: -
Debt/Eq: 0.02
Sales Q/Q: -100.00%
SMA50: -0.80%
Rel Volume: 0.43
Prev Close: 22.44
Employees: 118
LT Debt/Eq: 0.02
Earnings: Nov 06 AMC
SMA200: 56.95%
Avg Volume: 2.11M
Price: 22.16
IPO: Oct 02, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: -14.94% -100.00%
Trades:
Volume: 907,275
Change: -1.25%
Technical:
Latest News:
Immunome to Present at 2024 Bank of America Healthcare Conference | Business Wire neutral
IMNM
Summary: Immunome, Inc. announced that its President and CEO will present at the Bank of America Healthcare Conference on May 15, 2024.
Full article2024-05-08T12:01:40Z